Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Medicine (4)
Scientific Reports (2)
Journal of Human Genetics (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (4)
Amendments and Corrections (2)
Correspondence (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Diseases
Genetics
Immunology
Medical research
Neurology
Neuroscience

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–7 of 7 results

Advanced filters: Author: Mauro Pessia Clear advanced filters

Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis

Luigina Romani
Vasilis Oikonomou
Enrico Garaci
Amendments and Corrections22 Jun 2018
Nature Medicine

Volume: 24, P: 1481
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis

Luigina Romani
Vasilis Oikonomou
Enrico Garaci
Amendments and Corrections22 Jun 2018
Nature Medicine

Volume: 24, P: 1482
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis

Thymosin α1 is used in the clinic as a treatment in viral disease and acts as an anti-inflammatory. Here it was found to also correct the misfolding of mutant CTFR and potentiate its activity, thus improving outcome in a mouse model of cystic fibrosis.

Luigina Romani
Vasilis Oikonomou
Enrico Garaci
Research10 Apr 2017
Nature Medicine

Volume: 23, P: 590-600
Reply to ‘F508del-CFTR is not corrected by thymosin α1’

Luigina Romani
Claudia Stincardini
Enrico Garaci
Correspondence25 Jun 2018
Nature Medicine

Volume: 24, P: 891-893
Gain-of-function defects of astrocytic Kir4.1 channels in children with autism spectrum disorders and epilepsy

Federico Sicca
Elena Ambrosini
Mauro Pessia
ResearchOpen Access28 Sept 2016
Scientific Reports

Volume: 6, P: 1-15
A channelopathy mutation in the voltage-sensor discloses contributions of a conserved phenylalanine to gating properties of Kv1.1 channels and ataxia

Sonia Hasan
Cecilia Bove
Maria Cristina D’Adamo
ResearchOpen Access04 Jul 2017
Scientific Reports

Volume: 7, P: 1-13
A large cohort of myotonia congenita probands: novel mutations and a high-frequency mutation region in exons 4 and 5 of the CLCN1 gene

Raffaella Brugnoni
Dimos Kapetis
Renato Mantegazza
Research06 Jun 2013
Journal of Human Genetics

Volume: 58, P: 581-587